查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1543981

全球子宫内避孕器市场

Intrauterine Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球子宫内避孕器市场预计将达到 49 亿美元

子宫内避孕器的全球市场预计 2023 年为 38 亿美元，预计到 2030 年将达到 49 亿美元，2023-2030 年分析期间复合年增长率为 3.8%。释放荷尔蒙黄体素的子宫内避孕器是本报告分析的细分市场之一，预计复合年增长率为 3.4%，到分析期结束时将达到 34 亿美元。分析期间，非荷尔蒙含铜子宫内避孕器市场的复合年增长率预计为 4.7%。

美国市场预计将成长10亿美元，中国复合年增长率为3.6%

预计2023年美国子宫内避孕器市场规模将达10亿美元。中国作为全球第二大经济体，预计2030年市场规模将达到7.766亿美元，2023年至2030年复合年增长率为3.6%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 3.5% 和 3.2%。在欧洲，德国的复合年增长率预计为 3.9%。

全球子宫内避孕器市场—主要趋势与驱动因素总结

什么是子宫内避孕器？

子宫内避孕器 (IUD) 是一种插入子宫以防止怀孕的小型 T 型避孕器。子宫内避孕器因其高效、方便和可逆性而成为长期避孕的流行选择。子宫内避孕器可以是荷尔蒙型或非荷尔蒙型，前者会释放少量黄体素以阻止排卵，后者通常由铜製成，为精子创造有毒环境。子宫内避孕器可以防止怀孕数年，对于寻求长期、无麻烦避孕的女性来说是一个有吸引力的选择。子宫内避孕器可随时取出，让您立即恢復生育状态，使其更具吸引力。随着人们对子宫内避孕器益处的认识不断提高，子宫内避孕器正在成为世界各地女性首选的避孕方法。

科技进步如何形塑子宫内避孕器市场？

技术进步正在显着影响子宫内避孕器市场，特别是透过装置设计、材料和安全功能方面的创新。现代子宫内避孕器旨在提高插入的舒适度和便利性，有些型号具有较小的尺寸和柔性材料，以减少插入过程中的不适。荷尔蒙子宫内避孕器的进步导致了能够在较长时间内释放较低剂量荷尔蒙的装置的开发，从而在保持有效性的同时降低副作用的风险。此外，更安全的子宫内避孕器的引入，例如最大限度地降低穿孔和排放风险的子宫内避孕器，也有助于其广泛使用。这些创新使子宫内避孕器更容易获得并吸引更多女性，从而推动市场成长。

为什么避孕护理中对子宫内避孕器的需求不断增加？

由于人们越来越重视长期、可靠和低维护的避孕方法，避孕护理中对子宫内避孕器的需求正在增加。随着女性寻求日常口服避孕药和注射和贴片等短期避孕方法的替代品，子宫内避孕器提供了高效的解决方案，几乎不需要持续维护。人们越来越认识到子宫内避孕器的长期健康益处，例如不干扰母乳哺育和可能降低某些癌症的风险，也推动了需求。此外，全球延迟生育的趋势和计划生育服务的日益普及也促进了子宫内避孕器的日益普及。随着越来越多的女性优先考虑有效、方便和可逆的避孕措施，对子宫内避孕器的需求预计将继续增长。

推动子宫内避孕器市场成长的因素有哪些？

子宫内避孕器市场的成长是由技术进步、消费者偏好变化和避孕方法选择增加等多个因素所推动的。关键因素之一是子宫内避孕器设计和材料的进步，提高了舒适性、安全性和有效性，使其吸引了更广泛的女性。人们越来越偏好长期、低维护的避孕方法，这也推动了需求，因为子宫内避孕器是每日或短期避孕方法的可靠替代品。计划生育服务的增加和生殖健康的全球推广进一步促进了市场的成长。此外，人们对子宫内避孕器的健康益处的认识不断提高，包括其降低某些癌症风险的潜力及其对广大女性的适用性，正在推动其采用。随着这些趋势的不断发展，由于对有效、安全和方便的避孕解决方案的需求，子宫内避孕器市场预计将持续成长。

受访企业范例（44家知名企业）

  • Allergan PLC
  • ANI Pharmaceuticals, Inc.
  • Bayer AG
  • Besins Healthcare（Monaco）
  • CooperSurgical, Inc.
  • Eurogine, SL
  • HLL Lifecare Ltd.
  • HRA Pharma
  • OCON Medical Ltd.
  • Pregna International Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP12831

Global Intrauterine Devices Market to Reach US$4.9 Billion by 2030

The global market for Intrauterine Devices estimated at US$3.8 Billion in the year 2023, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Nonhormonal Copper-Containing IUD segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 3.6% CAGR

The Intrauterine Devices market in the U.S. is estimated at US$1.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$776.6 Million by the year 2030 trailing a CAGR of 3.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Intrauterine Devices Market - Key Trends & Drivers Summarized

What Are Intrauterine Devices and Why Are They a Popular Choice for Long-Term Contraception?

Intrauterine devices (IUDs) are small, T-shaped contraceptive devices that are inserted into the uterus to prevent pregnancy. They are a popular choice for long-term contraception due to their high effectiveness, convenience, and reversibility. IUDs can be hormonal or non-hormonal, with the former releasing small amounts of progestin to prevent ovulation and the latter, typically made of copper, creating an environment that is toxic to sperm. IUDs provide protection against pregnancy for several years, making them an attractive option for women seeking long-term, hassle-free contraception. Their ability to be removed at any time, allowing for a quick return to fertility, further enhances their appeal. As awareness of the benefits of IUDs increases, they are becoming a preferred contraceptive method among women worldwide.

How Are Technological Advancements Shaping the Intrauterine Devices Market?

Technological advancements are significantly shaping the intrauterine devices market, particularly through innovations in device design, materials, and safety features. Modern IUDs are being designed to offer improved comfort and ease of insertion, with some models featuring smaller sizes and flexible materials to reduce discomfort during placement. Advances in hormonal IUDs have led to the development of devices that release lower doses of hormones over longer periods, reducing the risk of side effects while maintaining efficacy. Additionally, the introduction of IUDs with enhanced safety profiles, such as devices that minimize the risk of perforation and expulsion, is contributing to increased adoption. These innovations are making IUDs more accessible and appealing to a broader range of women, driving growth in the market.

Why Is There an Increasing Demand for Intrauterine Devices in Contraceptive Care?

The demand for intrauterine devices is increasing in contraceptive care due to the growing emphasis on long-term, reliable, and low-maintenance birth control options. As women seek alternatives to daily oral contraceptives and short-term methods like injections or patches, IUDs offer a highly effective solution that requires little ongoing maintenance. The rising awareness of the long-term health benefits of IUDs, such as their non-interference with breastfeeding and their potential to reduce the risk of certain cancers, is also driving demand. Additionally, the global trend towards delaying childbirth and the increasing availability of family planning services are contributing to the growing popularity of IUDs. As more women prioritize effective, convenient, and reversible contraception, the demand for IUDs is expected to continue to rise.

What Factors Are Driving the Growth in the Intrauterine Devices Market?

The growth in the intrauterine devices market is driven by several factors related to technological advancements, changing consumer preferences, and the increasing availability of contraceptive options. One of the primary drivers is the advancement in IUD design and materials, which has improved the comfort, safety, and efficacy of these devices, making them more attractive to a wider range of women. The growing preference for long-term, low-maintenance contraception is also fueling demand, as IUDs offer a reliable alternative to daily or short-term methods. The increasing availability of family planning services and the global push for reproductive health and rights are further contributing to market growth, as more women gain access to contraceptive options. Additionally, the rising awareness of the health benefits of IUDs, such as their potential to reduce the risk of certain cancers and their suitability for a wide range of women, is driving adoption. As these trends continue to evolve, the intrauterine devices market is expected to experience sustained growth, driven by the need for effective, safe, and convenient contraceptive solutions.

Select Competitors (Total 44 Featured) -

  • Allergan PLC
  • ANI Pharmaceuticals, Inc.
  • Bayer AG
  • Besins Healthcare (Monaco)
  • CooperSurgical, Inc.
  • Eurogine, S.L
  • HLL Lifecare Ltd.
  • HRA Pharma
  • OCON Medical Ltd.
  • Pregna International Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Intrauterine Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Long-Acting Reversible Contraception Spurs Adoption of Intrauterine Devices (IUDs)
    • Advancements in IUD Technology Propel Innovation in Contraceptive Solutions
    • Shift Towards Non-Hormonal and Hormonal IUDs Expands Market Opportunities
    • Increasing Use of IUDs in Family Planning Programs Globally
    • Role of IUDs in Reducing Unintended Pregnancies
    • Advancements in IUD Insertion Techniques and Device Safety Propel Market Growth
    • Emerging Markets Present New Opportunities for IUD Manufacturers
    • Rise in Demand for Targeted Temperature Management Spurs Adoption of Intravascular Temperature Management Devices
    • Advancements in Cooling and Heating Technology Propel Innovation in Temperature Management
    • Shift Towards Minimally Invasive Temperature Regulation Expands Market Opportunities
    • Increasing Use of Intravascular Temperature Management in Post-Cardiac Arrest Patients
    • Growing Importance of Hypothermia Induction in Trauma and Surgery
    • Advancements in Catheter-Based Cooling and Warming Systems Propel Market Growth
    • Push for Cost-Effective and Efficient Temperature Management Solutions
    • Role of Intravascular Temperature Management in Improving Patient Outcomes
    • Growing Focus on Patient Safety and Reducing Complications
    • Integration of Temperature Management Devices with Advanced Monitoring Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intrauterine Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intrauterine Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intrauterine Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Intrauterine Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hormonal Progestogen-Releasing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hormonal Progestogen-Releasing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hormonal Progestogen-Releasing IUD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Nonhormonal Copper-Containing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Nonhormonal Copper-Containing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Nonhormonal Copper-Containing IUD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for 15 - 24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for 15 - 24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for 15 - 24 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for 25 - 34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for 25 - 34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for 25 - 34 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for 35 - 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for 35 - 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for 35 - 44 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Above 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Above 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Above 44 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Community Healthcare Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Community Healthcare Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Community Healthcare Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Intrauterine Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Intrauterine Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION